Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apial Pharma is a Spanish biotechnology company focused on the development of innovative pharmaceutical products, particularly in the field of cannabinoid-based therapies. The company leverages its expertise in drug delivery and formulation to create treatments for pain management, inflammation, and various neurological conditions. Apial Pharma aims to bridge the gap between traditional pharmacology and the therapeutic potential of cannabinoids through rigorous scientific research and clinical development. Their current efforts are centered on optimizing the bioavailability and safety profiles of their lead compounds to address unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apialpharma.